CARDIOVASCULAR & IMAGING RESEARCH FOUNDATION OF NY (EIN 202597925) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2005

Legal Domicile

Principal Officer

David Rausnitz

Phone

5162411314

Tax Period

2024-01-01 to 2024-12-31

CARDIOVASCULAR & IMAGING RESEARCH FOUNDATION OF NY, founded in 2005, is a micro nonprofit in the Medical Research sector that reported $87K in total revenue in fiscal year 2024. Expenses of $667K exceeded revenue, resulting in a 668% operating deficit.

Mission

Cardiovascular & Imaging Research Foundation of New York's mission statement is to support medical research and education and other projects aimed at treating and preventing cardiovascular diseases.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $85,695

Program Service Revenue $0

Investment Income $390

Other Revenue $816

TOTAL REVENUE $86,901

Expense Breakdown

Grants Paid $236,174

Salaries & Benefits $380,211

Fundraising Expenses $0

Program Expenses $632,337

Other Expenses $50,735

TOTAL EXPENSES $667,120

Year-over-Year Comparison

	2024	2023	Change
Revenue	$86,901	$90,731	0.0%
Expenses	$667,120	$398,402	+0.7%
Net Income	$-580,219	$-307,671	+0.9%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$30,000

Total Directors

Key Employees

$100,000

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Michael Poon	Principal Investigator	14	Highest	$200,000	$0	$200,000
Pamela Noack	Research Director and Investigator	10	Key Emp	$100,000	$0	$100,000
Michael J Cortegiano	Treasurer	10	Officer	$30,000	$0	$30,000
Charles Gargano	Drector	1	Director	$0	$0	$0
Howard Printz	Director	1	Director	$0	$0	$0
Gerald Rausnitz	Director	1	Director	$0	$0	$0
David Rausnitz	President	2	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$86,901	$667,120	$421,491	$-580,219
2023	$90,731	$398,402	$1,001,710	$-307,671
2022	$179,560	$382,859	$1,312,848	$-203,299
2021	$1,026,272	$729,125	$1,516,147	$297,147
2020	$304,709	$280,104	$1,219,000	$24,605

CARDIOVASCULAR & IMAGING RESEARCH FOUNDATION OF NY